"Ferrosoferric Oxide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Iron (II,III) oxide (Fe3O4). It is a black ore of IRON that forms opaque crystals and exerts strong magnetism.
| Descriptor ID |
D052203
|
| MeSH Number(s) |
D01.490.100.375 D01.490.200.350 D01.578.285
|
| Concept/Terms |
Ferrosoferric Oxide- Ferrosoferric Oxide
- Oxide, Ferrosoferric
- Ferriferrous Oxide
- Oxide, Ferriferrous
|
Below are MeSH descriptors whose meaning is more general than "Ferrosoferric Oxide".
Below are MeSH descriptors whose meaning is more specific than "Ferrosoferric Oxide".
This graph shows the total number of publications written about "Ferrosoferric Oxide" by people in this website by year, and whether "Ferrosoferric Oxide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 3 | 4 |
| 2016 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ferrosoferric Oxide" by people in Profiles.
-
Goberna-Ferr?n S, Asta MP, Zareeipolgardani B, Bureau S, Findling N, Simonelli L, Greneche JM, Charlet L, Fern?ndez-Mart?nez A. Influence of Silica Coatings on Magnetite-Catalyzed Selenium Reduction. Environ Sci Technol. 2021 03 02; 55(5):3021-3031.
-
Zanaty M, Chalouhi N, Starke RM, Jabbour P, Hasan D. Molecular Imaging in Neurovascular Diseases: The Use of Ferumoxytol to Assess Cerebral Aneurysms and Arteriovenous Malformations. Top Magn Reson Imaging. 2016 Apr; 25(2):57-61.
-
Chalouhi N, Jabbour P, Hasan D. Inflammation, macrophages, and targeted imaging in intracranial aneurysms. World Neurosurg. 2014 Feb; 81(2):206-8.
-
Chalouhi N, Jabbour P, Magnotta V, Hasan D. Molecular imaging of cerebrovascular lesions. Transl Stroke Res. 2014 Apr; 5(2):260-8.
-
Chalouhi N, Jabbour P, Magnotta V, Hasan D. The emerging role of ferumoxytol-enhanced MRI in the management of cerebrovascular lesions. Molecules. 2013 Aug 13; 18(8):9670-83.
-
Hasan DM, Chalouhi N, Jabbour P, Magnotta VA, Kung DK, Young WL. Imaging aspirin effect on macrophages in the wall of human cerebral aneurysms using ferumoxytol-enhanced MRI: preliminary results. J Neuroradiol. 2013 Jul; 40(3):187-91.
-
Hasan D, Chalouhi N, Jabbour P, Dumont AS, Kung DK, Magnotta VA, Young WL, Hashimoto T, Winn HR, Heistad D. Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study. Stroke. 2012 Dec; 43(12):3258-65.
-
Yoshikawa T, Mitchell DG, Hirota S, Ohno Y, Oda K, Maeda T, Fujii M, Sugimura K. Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions. J Magn Reson Imaging. 2006 May; 23(5):712-9.